- Recommendation ID
- NG23/7
- Question
Do different types of progestogen (for example, micronised progesterone) alter the risks of breast cancer or cardiovascular disease?
- Any explanatory notes
(if applicable) For a short explanation of why the committee made this recommendation for research, see the rationale section on effect of combined HRT on specific health outcomes in people aged 45 or over .
Full details of the evidence and the committee's discussion are in:
evidence review C: cardiovascular disease and stroke
Source guidance details
- Comes from guidance
- Menopause: identification and management
- Number
- NG23
- Date issued
- November 2015
Other details
| Is this a recommendation for the use of a technology only in the context of research? | No |
| Is it a recommendation that suggests collection of data or the establishment of a register? | No |
| Last Reviewed | 28/01/2025 |